Collectively, we find that rrDLBCL tumors are prone to DNA losses, gains, and rearrangements that result in amplification of lymphoma driver genes (e.g., MYC, BCL2, IL10) or depletion of critical tumor suppressor genes (e.g., TOP3A, CD70, TP53). This evidence concerns the gene TOP3A and lymphoma.